ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVS Stock Price » NVS Stock News

Novartis Share News

 Novartis Ag Basel Stock Price
NVS Stock Price
 Novartis Ag Basel Stock Chart
NVS Stock Chart
 Novartis Ag Basel Stock News
NVS Stock News
 Novartis Ag Basel Company Information
NVS Company Information
 Novartis Ag Basel Stock Trades
NVS Stock Trades

EUROBONDS: Primary Sees Limited Deal Flow, Indexes Tighten

By Carol Dean The European primary bond market saw limited deal flow Thursday with issuers coming from opposite ends of the rating spectrum as the cost of insuring European corporate debt against default pushed tighter on positive earnings results. Paints and coatings company Akzo Nobel NV (AKZA.AE) said its second quarter revenue was up due to price increases while volumes were down. Akzo Nobel's five-year credit default tightened 9 basis points on the news to 144 basis points to Wednesday's close according to data provider Markit. Electrolux AB (ELUX-B.SK), Novartis AG (NOVN.VX) and Alstom SA (ALO.FR) were among the other companies posting better than expected results boosting market sentiment and pushing corporate secondary indexes lower. Swedish home-appliance maker Electrolux continued its resurgence with a forecast-beating rise in profit, driven by price increases in the crucial North American market. Novartis said 2Q profit has improved slightly, adding that growth in newly launched drugs more than offset weaker sales of its best-selling product Diovan, which has been seeing pressure from generics. And French power engineering and train company Alstom said Thursday that revenues over the April-June period, the first quarter of its fiscal year, rose 6% year-on-year and new orders were boosted by demand for the company's turbines and trains in emerging markets. Against this backdrop, sub investment-grade Irish packaging company Ardagh group is pushing ahead with plans to tap two of its existing high yield bonds for an additional amount of $920 million equivalent. Ardagh, through Ardagh Packaging Finance, will increase its euro- and dollar-denominated 7.375% bond maturing October 2017 for a $700 million equivalent, and its dollar-denominated 9.125% bond maturing in October 2020 for $220 million. Ardagh has set a yield on its dollar portion of the 2017 bond at 6% to 6.25% and on the euro 2017 tranche a yield of 6.25% to 6.50%. A yield of 8.25% to 8.50% has been set on the $200 million 2020 tap. The proceeds will finance the acquisition of Anchor Glass, the third-largest glass container manufacturer in the U.S. Triple A-rated European Investment Bank, or EIB has set pricing on its dollar-denominated, benchmark-sized, five-year bond in the area of 40 basis points over midswaps. Meanwhile, the gap between the heroes and villains of the euro-zone bond-market drama became clearer Thursday as Spain was forced to pay sharply higher borrowing costs at a short-term bond auction while French yields fell. Spain's higher yields and tepid demand from investors reflect nagging concerns about the execution of its banking bailout and the finances of its autonomous regions. At 1140 GMT, the iTraxx Europe index, which comprises 125 high-grade borrowers, 25 of which are banks and insurers, was at 160/161 basis points, three basis points tighter than on Wednesday, according to data-provider Markit. The Crossover index of 40 mostly sub-investment-grade European corporate borrowers was 13 basis points tighter at 637/640.50 basis points. (Sarka Halas and Serena Ruffoni contributed to this article) Write to Carol Dean at carol.dean@dowjones.com Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stock News for Novartis (NVS)
DateTimeHeadline
05/20/201306:52:34Affymetrix Names Gavin Wood Chief Financial Officer
05/15/201319:00:14Novartis Considers Possible Bid for Actavis
05/10/201317:23:16Correction to Story on Novartis's FDA Approval for Ilaris
05/10/201307:45:16Novartis: FDA Approves Ilaris for Serious Form of Childhood Arthritis
05/07/201308:01:41Endo Health Swings to First-Quarter Profit On Strong Generic...
04/30/201311:58:44Auction of Brazilian Drug Company Ache Stalls on Differences...
04/26/201315:50:18U.S. Sues Novartis for Allegedly Paying Kickbacks
04/25/201305:40:23Mixed Results for Drug Companies
04/24/201306:50:15Novartis Boosted by Drug Launches
04/24/201302:00:22Novartis 1Q Net Profit Misses Expectations; New Products Deliver
04/24/201301:50:21U.S. Accuses Novartis Of Kickbacks
04/23/201318:01:35U.S. Accuses Novartis of Paying Kickbacks to Pharmacies in Lawsuit
04/22/201317:31:18Anglo American Shareholder Opposition to Remuneration Report...
04/16/201312:27:18EUROPE MARKETS: Europe Stocks Extend Losses To Third Day
04/16/201306:41:33EUROPE MARKETS: Europe Stocks Hold Losses After German ZEW
04/15/201312:18:49EUROPE MARKETS: Europe Stocks Slide After China GDP; Miners Sink
04/15/201305:07:09EUROPE MARKETS: Europe Stocks Slide After China GDP, Miners Sink
04/12/201318:48:24Portola Pharmaceuticals Files Plans for $150 Million IPO
04/03/201312:10:06Merck Unit, Sun Pharma File Patent Suit Against Glenmark
04/01/201311:15:49MARKET SNAPSHOT: U.S. Stocks Retreat After Manufacturing Data

Novartis and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad